Innovative clinical supply solutions
In today’s challenging environment, every clinical study is different and changes can occur during project development which require unique, responsive solutions. Catalent offers flexible services designed to keep studies moving.
Catalent has over 25 years’ experience in providing comprehensive clinical supply services, and has supported over 5,000 trials globally. Through eight cGMP clinical supply facilities across the U.S., Europe and Asia-Pacific region, and a global network of 50+ depots with a combined capacity of more than 1,400,000 cubic feet of controlled temperature space, Catalent manages more than 150,000 shipments per year to over 80 countries.
Catalent’s innovative FastChain™ demand led supply solution enables clinical sites to receive patient kits within a matter of days instead of weeks and can reduce clinical waste from more than 200% to less than 20%.
Catalent offers customers a full range of tailored solutions designed to address today’s complex clinical supply challenges, from clinical supply management and forecasting, comparator and reference product sourcing, primary and secondary packaging, labelling, clinical storage from controlled room temperature to cryogenic, global cold chain distribution, and clinical returns and destruction.
Speciality handling services are available for temperature, light and oxygen sensitive products, DEA Schedule I-V controlled drug substances and potent/cytotoxic products.
Catalent. More products. Better treatments. Reliably supplied™.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
INTERPHEX 2025: Use of Walk-In Chambers for Bio/Pharma Development and Manufacturing
April 2nd 2025Sitting down with the PharmTech Group at INTERPHEX 2025, Christopher Murphy, director of Global Business Development and Service Customer Support at Environmental Specialties, discusses the design and critical role of walk-in chambers in the bio/pharmaceutical industry.
